StockData
Gyre Therapeutics, Inc. logo

Gyre Therapeutics, Inc. (GYRE) stock

GYRENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/3020% below fair value
$4.21−0.31 (-6.86%)

Close on Nov 20, 2026Market cap $469.46MP/E –Yield –

Gyre Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

For fiscal 2013 it was $1.14M, down 42.8% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2013Dec 31, 2013$1.14M-42.8%
FY2012Dec 31, 2012$1.99M-38.4%
FY2011Dec 31, 2011$3.23M+5.5%
FY2010Dec 31, 2010$3.06M–

More Gyre Therapeutics figures

See a number that looks wrong?